Concepedia

Cryptococcosis Therapy

Cryptococcosis Therapy is a medical treatment strategy, within the domain of antifungal agents, specifically designed to manage and eradicate infections caused by the fungal pathogen *Cryptococcus* species, particularly *C. neoformans* and *C. gattii*, through the targeted application of antifungal drugs such as amphotericin B, flucytosine, and fluconazole.

830

Publications

44.3K

Citations

3.6K

Authors

1K

Institutions

Publications per year

2017–2026

133

Parents

Publications

830

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

John R. Perfect, William E. Dismukes, Françoise Dromer et al. · Clinical Infectious Diseases · 2010 · 2.7K citations · Full text

, , +15

Practice Guidelines for the Management of Cryptococcal Disease

M. S. Saag, Richard Graybill, Robert A. Larsen et al. · Clinical Infectious Diseases · 2000 · 1.1K citations · Full text

, , +15

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

John E. Bennett, William E. Dismukes, Richard J. Duma et al. · New England Journal of Medicine · 1979 · 871 citations

, , +12

Infections with<i>Cryptococcus neoformans</i>in the Acquired Immunodeficiency Syndrome

Steven L. Chuck, Merle A. Sande · New England Journal of Medicine · 1989 · 801 citations

, , +12

Cryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole Therapy

Peter G. Pappas, John R. Perfect, Gretchen A. Cloud et al. · Clinical Infectious Diseases · 2001 · 638 citations

, , +14

1–5 of 830

Authors

3.6K

  1. JR
    John R. Graybill

    The University of Texas at San Antonio Health Science Center, United States

    23 publications · 4.1K citations

    20

    h-index

  2. FD
    Françoise Dromer

    Institut Pasteur, France

    19 publications · 4.5K citations

    18

    h-index

  3. OL
    Olivier Lortholary

    Université Paris Cité, France

    21 publications · 4.2K citations

    18

    h-index

  4. JR
    John R. Perfect

    Duke Medical Center, United States

    16 publications · 5.3K citations

    15

    h-index

  5. TS
    Thomas S. Harrison

    St George's, University of London, United Kingdom

    15 publications · 4.5K citations

    14

    h-index

1–5 of 3.6K

Institutions

1K

  1. The University of Sydney

    Sydney, Australia

    21 h-index

    90 publications

    8.3K citations

  2. Institut Pasteur

    Paris, France

    20 h-index

    60 publications

    10.1K citations

  3. Santa Clara Valley Medical Center

    San Jose, United States

    17 h-index

    43 publications

    3.4K citations

  4. Albert Einstein College of Medicine

    Bronx, United States

    16 h-index

    44 publications

    4.2K citations

  5. Université Paris Cité

    Paris, France

    15 h-index

    38 publications

    5.2K citations

  6. Duke University

    Durham, United States

    15 h-index

    52 publications

    17.1K citations

  7. National Institutes of Health

    Bethesda, United States

    15 h-index

    63 publications

    17.7K citations

  8. Duke Medical Center

    Durham, United States

    15 h-index

    23 publications

    4.9K citations

1–8 of 1K

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 66 publications · 3.5K citations

    34

    h-index

  2. Clinical Infectious Diseases

    CID · 40 publications · 7.5K citations

    30

    h-index

  3. Medical Mycology

    40 publications · 1.4K citations

    21

    h-index

  4. PubMed

    Repository · 57 publications · 1.6K citations

    21

    h-index

  5. Journal of Antimicrobial Chemotherapy

    JAC · 21 publications · 834 citations

    18

    h-index

1–5